Liaoning Chengda BiotechnologyLtd Balance Sheet Health
Financial Health criteria checks 6/6
Liaoning Chengda BiotechnologyLtd has a total shareholder equity of CN¥9.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥9.9B and CN¥486.3M respectively. Liaoning Chengda BiotechnologyLtd's EBIT is CN¥399.9M making its interest coverage ratio -5.1. It has cash and short-term investments of CN¥5.3B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -5.1x |
| Cash | CN¥5.34b |
| Equity | CN¥9.45b |
| Total liabilities | CN¥486.30m |
| Total assets | CN¥9.93b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688739's short term assets (CN¥7.0B) exceed its short term liabilities (CN¥378.8M).
Long Term Liabilities: 688739's short term assets (CN¥7.0B) exceed its long term liabilities (CN¥107.5M).
Debt to Equity History and Analysis
Debt Level: 688739 is debt free.
Reducing Debt: 688739 had no debt 5 years ago.
Debt Coverage: 688739 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688739 has no debt, therefore coverage of interest payments is not a concern.